-- ------------- -------------- ------------------- -------------------
Thursday , February 9 2023

MOH authorizes use of Bamlanivimab to treat mild to moderate cases of COVID

This post has been read 14612 times!

KUWAIT CITY, Dec 1: Kuwait’s Ministry of Health (MoH) authorized the drug “Bamlanivimab” for emergency use to treat mild to moderate cases of COVID-19 in adult patients and kids over 12 years old who have risk factors that make them more vulnerable.

Assistant Undersecretary for Drug and Food Control Affairs Dr Abdullah Al- Bader said, in a press statement on Tuesday, that the last emergency use of Baricitinib was licensed to be used as an added drug to Remdesivir to treat COVID-19 cases in adult patients and children over two years old who are receiving hospital treatment with ventilators. (KUNA)

Check Also

Kuwait detects several cases of coronavirus XBB variant

This post has been read 14613 times! KUWAIT CITY, Oct 26: The Ministry of Health …